Canopy Partners’s Advantest Corp ATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$814K Sell
3,684
-82
-2% -$18.1K 0.24% 83
2026
Q2
$784K Buy
3,766
+1
+0% +$208 0.24% 82
2026
Q1
$511K Sell
3,765
-11
-0.3% -$1.49K 0.18% 108
2025
Q4
$477K Sell
3,776
-172
-4% -$21.7K 0.16% 117
2025
Q3
$397K Buy
3,948
+64
+2% +$6.43K 0.13% 133
2025
Q2
$287K Buy
+3,884
New +$287K 0.11% 161
2025
Q1
– Sell
-3,991
Closed -$227K – 224
2024
Q4
$227K Buy
+3,991
New +$227K 0.09% 170

Other funds holding ATE

Canopy Partners's ATE Position: Q3 2026 in Review

Canopy Partners reduced its Advantest Corp (ATE) stake by 2.2% in Q3 2026, selling an estimated $18.1K and leaving 3,684 shares worth $814K. The position accounts for 0.24% of the portfolio, ranked #83.

Canopy Partners first reported a position in ATE in Q4 2024 and has held it in 7 quarters since. 21 funds tracked by Wall St. Rank hold ATE as of Q3 2026.

  • Canopy Partners held 3,684 shares of Advantest Corp worth $814K as of Q3 2026.
  • Canopy Partners sold 82 Advantest Corp shares in Q3 2026, an estimated $18.1K.
  • Advantest Corp made up 0.24% of Canopy Partners's portfolio in Q3 2026, its #83 holding.
  • Canopy Partners first reported a position in Advantest Corp in Q4 2024 and has held it in 7 quarters since.
  • 21 funds tracked by Wall St. Rank held Advantest Corp as of Q3 2026.

Based on Canopy Partners's 13F filing for Q3 2026, filed 28 Oct 2026.